Home ›
Trademark Categories ›
Pharmaceuticals ›
2019 ›
OP ›
OPDIVO ZENCEIVE
Trademark search for:
OPDIVO ZENCEIVE
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2019-11-06 — Application filed
2019-11-09 — Application filed
2019-11-13 — Application filed
2020-01-24 — Assigned to examiner
2020-02-05 — Final disposition recorded
2020-02-05 — Final disposition recorded
2020-02-05 — Final disposition recorded
2020-08-05 — Teas/email correspondence entered
2020-08-05 — Office action issued
2020-08-05 — Correspondence received in law office
2020-09-06 — Final disposition recorded
2020-09-06 — Final disposition recorded
2020-09-06 — Final disposition recorded
2021-03-02 — Office action issued
2021-03-02 — Correspondence received in law office
2021-03-03 — Teas/email correspondence entered
2021-04-03 — Final disposition recorded
2021-04-03 — Final disposition recorded
2021-04-03 — Final disposition recorded
2021-10-04 — Office action issued
2021-10-12 — Assigned to lie
2021-10-18 — Assigned to lie
2021-10-19 — Teas/email correspondence entered
2021-10-19 — Correspondence received in law office
2021-11-18 — Approved for pub - principal register
2021-12-08 — Notification of notice of publication e-mailed
2021-12-28 — Published for opposition
2021-12-28 — Official gazette publication confirmation e-mailed
2022-02-22 — Noa e-mailed - sou required from applicant
2022-07-27 — Sou teas extension received
2022-07-27 — Sou extension 1 filed
2022-07-27 — Sou extension 1 granted
2022-07-29 — Notice of approval of extension request e-mailed
2023-02-13 — Sou teas extension received
2023-02-13 — Sou extension 2 filed
2023-02-13 — Sou extension 2 granted
2023-02-15 — Notice of approval of extension request e-mailed
2023-08-02 — Teas change of owner address received
2023-08-02 — Teas change of correspondence received
2023-08-02 — Applicant/correspondence changes (non-responsive) entered
2023-09-25 — Application abandoned
2023-09-25 — Application abandoned
2023-09-25 — Final status recorded
Owner Information
Bristol-Myers Squibb Company
Bristol-Myers Squibb Company
Correspondent
Marilyn F. Kelly BRISTOL-MYERS SQUIBB COMPANY
Filing Details
Filing Date:
Status Date:
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.
